Literature DB >> 32770380

Decreased hemoglobin as a quantifiable indicator of renal arterial embolization in post-percutaneous nephrolithotomy hemorrhage.

Ruitu Ran1, Ruiyuan Zhang2, Ye Xie1, Zhikang Yin3.   

Abstract

To determine quantifiable indicators for post-percutaneous nephrolithotomy (PCNL) renal arterial embolization. A total of 2043 patients who underwent PCNL from September 2012 to March 2018 were reviewed retrospectively. Post-operative hemorrhage patients were extracted and divided into two groups according to treatment methods (conservative methods or super-selective renal arterial embolization [SRAE]). Demographic characteristics and hemorrhage outcomes were compared between the two groups by univariable analysis. Multivariable logistic regression was used to reveal the association between hemorrhage outcome factors and SRAE. A receiver operating characteristic (ROC) curve was drawn to determine the optimized cut-off value for SRAE. We identified 71 patients who had post-PCNL hemorrhage. Seventeen and 54 patients comprised the SRAE and conservative groups, respectively. No significant differences in demographic characteristics were found between the two groups. Univariate analysis showed that the differences in decreased hemoglobin (Hb), hemorrhage types, and transfusion were significant between the two groups (p < 0.001). Multivariable analysis showed that the decreased Hb was closely associated with the risk of SRAE. The ROC curve showed that an adjusted Hb decrease of 3.45 g/dL was an optimum indicator (AUC = 0.925). Decreased Hb is an indicator for SRAE after PCNL. When the adjusted decrease in Hb is ≥ 3.45 g/dL, SRAE should be performed regardless of the manifestations of hemorrhage.

Entities:  

Keywords:  Embolization; Hemoglobin; Hemorrhage; Percutaneous nephrolithotomy

Mesh:

Substances:

Year:  2020        PMID: 32770380      PMCID: PMC7960596          DOI: 10.1007/s00240-020-01206-6

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  24 in total

Review 1.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

Authors:  S Schulman; U Angerås; D Bergqvist; B Eriksson; M R Lassen; W Fisher
Journal:  J Thromb Haemost       Date:  2009-10-30       Impact factor: 5.824

Review 2.  Worldwide Trends of Urinary Stone Disease Treatment Over the Last Two Decades: A Systematic Review.

Authors:  Robert M Geraghty; Patrick Jones; Bhaskar K Somani
Journal:  J Endourol       Date:  2017-06       Impact factor: 2.942

3.  Vascular complications after percutaneous nephrolithotomy: are there any predictive factors?

Authors:  Aneesh Srivastava; Kamal Jeet Singh; Amit Suri; Deepak Dubey; Anant Kumar; Rakesh Kapoor; Anil Mandhani; Sunil Jain
Journal:  Urology       Date:  2005-07       Impact factor: 2.649

Review 4.  Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Guy Maddern; Moritz Koch; Thomas J Hugh; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Jean-Nicolas Vauthey; Myrddin Rees; Rene Adam; Ronald P Dematteo; Paul Greig; Val Usatoff; Simon Banting; Masato Nagino; Lorenzo Capussotti; Yukihiro Yokoyama; Mark Brooke-Smith; Michael Crawford; Christopher Christophi; Masatoshi Makuuchi; Markus W Büchler; Jürgen Weitz
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

5.  A multicentre retrospective study of transcatheter angiographic embolization in the treatment of delayed haemorrhage after percutaneous nephrolithotomy.

Authors:  Long Li; Yan Zhang; Yong Chen; Kang-Shun Zhu; De-Ji Chen; Xin-Qiao Zeng; Xiao-Bai Wang
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

Review 6.  Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs.

Authors:  Omer A Raheem; Yash S Khandwala; Roger L Sur; Khurshid R Ghani; John D Denstedt
Journal:  Eur Urol Focus       Date:  2017-04-24

7.  Functional and morphological effects of postpercutaneous nephrolithotomy superselective renal angiographic embolization.

Authors:  Ahmed R el-Nahas; Ahmed A Shokeir; Tarek Mohsen; Hossam Gad; Ahmed M el-Assmy; Tarek el-Diasty; Hamdy A el-Kappany
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

8.  Percutaneous nephrolithotomy for staghorn calculi: a single center's experience over 15 years.

Authors:  Frédéric Soucy; Raymond Ko; Mordechai Duvdevani; Linda Nott; John D Denstedt; Hassan Razvi
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

9.  Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study.

Authors:  Santosh Kumar; Muninder Singh Randhawa; Raguram Ganesamoni; Shrawan K Singh
Journal:  J Urol       Date:  2012-10-30       Impact factor: 7.450

10.  Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL).

Authors:  Stephen R Keoghane; Richard J Cetti; Ann E Rogers; Byron H Walmsley
Journal:  BJU Int       Date:  2012-09-07       Impact factor: 5.588

View more
  3 in total

1.  Factors affecting hemostasis in the control of iatrogenic renal hemorrhage.

Authors:  Han Bao; Lingjie Shao; Xiaojun Man; Wenda Lin; Xitong Zhang; Xiangjun Han
Journal:  World J Urol       Date:  2022-02-27       Impact factor: 4.226

2.  Predictive value of serum adiponectin and hemoglobin levels for vascular cognitive impairment in ischemic stroke patients.

Authors:  Zhouling Li; Manlian Zhu; Cheng Meng; Hai Lin; Lifen Huang
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 1.088

3.  Retroperitoneal laparoscopic renorrhaphy for post-percutaneous nephrolithotomy hemorrhage: a case report.

Authors:  Jianhua Lan; Guohua Huang; Sixiang Chen; Wenjun Zhou; Hai Yang
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.